|
Press Releases |
|
|
|
Tuesday, April 11, 2023 |
|
TrialWire Patient Recruitment Platform Launches AI Pre-recruit to Cut Recruitment Time by 50% |
The award-winning TrialWire(TM) Patient Recruitment Platform, the most secure and rapid digital patient recruitment solution to reverse failing recruitment, today announced the rollout of Pre-recruit, the pre-recruitment solution that guarantees success before your study starts. more info >> |
|
Wednesday, July 20, 2022 |
|
TrialWire Technology Platform Rolls Out World First SMS/Text Patient Contact System Across all Studies Globally |
TrialWire(TM) Technology Platform, the most secure and rapid digital patient recruitment Platform for trial rescue, today announced the rollout of the proprietary SMS/Text patient contact system across all studies globally. more info >> |
|
Monday, July 18, 2022 |
|
TrialWire Technology Platform Announces Success-based Patient Recruitment Plan |
TrialWire(TM) Technology Platform, the fastest and most secure digital patient recruitment Platform for trial rescue powered by Salesforce Health Cloud, today announced the launch of its success-based recruitment plan. more info >> |
|
Wednesday, January 5, 2022 |
|
B-cell lymphoma clinical trials now open on the TrialWire Platform |
TrialWire(TM) is pleased to announce new B-cell lymphoma clinical studies are now available on the TrialWire Platform. more info >> |
|
Autism clinical trials now open on the TrialWire Platform |
TrialWire(TM) is pleased to announce new Autism (ASD) clinical studies are now available on the TrialWire Platform. more info >> |
|
Friday, March 26, 2021 |
|
TrialWire launches StudyBoost, the Clinical Trial Insurance Plan |
TrialWire(TM), the secure online Patient Recruitment Platform, announces the launch of StudyBoost, a monthly insurance plan that provides an instant patient recruitment boost at any time, across one or every site, depending on recruitment needs. more info >> |
|
Wednesday, March 24, 2021 |
|
TrialWire launches StudyBoost, the Clinical Trial Insurance Plan |
TrialWire(TM), the most secure digital Patient Recruitment Platform, announces the launch of StudyBoost, the monthly insurance plan that provides an instant patient recruitment boost at any time, across one or all sites depending on recruitment needs. more info >> |
|
Tuesday, July 12, 2016 |
|
Hepatitis B Clinical Trial opens in Australia |
Hepatitis B is a virus that is spread through contact with the blood or bodily fluids of an infected person. more info >> |
|
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Microex Launches Web3.0 Financial Trading Solution - Pioneering Innovation in Financial Technology
Apr 18, 2024 14:00 HKT/SGT
|
|
|
Toyota Launches All-New Land Cruiser "250" Series in Japan
Apr 18, 2024 13:39 JST
|
|
|
To acquire stake in Hangzhou Bizike, Phoenitron Holdings has eye on trillion-dollar e-commerce market
Apr 18, 2024 11:51 HKT/SGT
|
|
|
Fujitsu and Oracle collaborate to deliver sovereign cloud and AI capabilities in Japan
Apr 18, 2024 11:14 JST
|
|
|
The Executive Centre Announces Record Revenue in FY2023 Annual Results
Apr 18, 2024 10:00 HKT/SGT
|
|
|
Eisai: Research on Treatments for Alzheimer's Disease Based on Its Pathological Mechanisms Recieves Award for Science and Technology (Research Category)
Apr 18, 2024 10:53 JST
|
|
|
All-New Triton Confirmed as First Double-Cab Pickup Truck to Achieve 2024 Five-Star ANCAP Safety Rating
Apr 18, 2024 9:22 JST
|
|
|
The Rapidly Evolving Real Estate Landscape: Redefine Real Estate Summit Connects Key Players in South East Asia
Apr 18, 2024 08:11 HKT/SGT
|
|
|
Prestigious titles for top developers at the 14th PropertyGuru Asia Property Awards (Singapore)
Apr 18, 2024 08:00 HKT/SGT
|
|
|
Eesee Implements Blockpass for Compliance in Digital Assets Marketplace
Apr 18, 2024 07:00 HKT/SGT
|
|
|
A new spin on materials analysis
Apr 17, 2024 22:00 HKT/SGT
|
|
|
Hong Kong Interior Design Firm Junee (JUNE) to Debut on the Nasdaq
Apr 17, 2024 21:30 HKT/SGT
|
|
|
To acquire stake in Hangzhou Bizike, Phoenitron Holdings has eye on trillion-dollar e-commerce market
Apr 17, 2024 20:06 HKT/SGT
|
|
|
Eisai's Antiepileptic Drug Fycompa Injection Formulation Launched In Japan
Apr 17, 2024 16:17 JST
|
|
|
CIRC Announces 2023 Annual Results
Apr 17, 2024 13:37 HKT/SGT
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|